Immunological efficacy of glycoconjugates derived from Vibrio cholerae O1 serotype Ogawa detoxified LPS in mice

Journal of Medical Microbiology

Volumn 59, Issue 12, 2010, Pages 1440-1448

  Paulovičová, Ema ^a   Korcová, Jana ^a   Farkaš, Pavol ^a   Bystrický, Slavomír ^a  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; BACTERIUM LIPOPOLYSACCHARIDE; CD19 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CHOLERA VACCINE; DE O ACYLATED LIPOPOLYSACCHARIDE GLYCOCONJUGATE; DRUG CARRIER; GLUCAN; GLYCOCONJUGATE; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; IMMUNOGLOBULIN G2B; IMMUNOGLOBULIN G3 ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; IMMUNOGLOBULIN RECEPTOR; O SPECIFIC POLYSACCHARIDE GLYCOCONJUGATE; PLACEBO; POLYSACCHARIDE VACCINE; UNCLASSIFIED DRUG;

ACYLATION AND DEACYLATION; ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; CD4 CD8 RATIO; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHOLERA; CONTROLLED STUDY; DETOXIFICATION; DRUG CONJUGATION; DRUG DESIGN; DRUG EFFICACY; DRUG FORMULATION; FEMALE; HUMORAL IMMUNITY; IMMUNOGENICITY; MOUSE; NEUTROPHIL; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; RESPIRATORY BURST; TH1 CELL; VACCINATION; VACCINE PRODUCTION; VIBRIO CHOLERAE;

ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, BACTERIAL; CHOLERA VACCINES; FEMALE; GLYCOCONJUGATES; INJECTIONS, INTRAPERITONEAL; INJECTIONS, SUBCUTANEOUS; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED BALB C; VIBRIO CHOLERAE;

EID: 78649436891     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.020875-0     Document Type: Article

References (38)

1. Adams, L. B. & Siebeling, R. J. (1984). Production of Vibrio cholerae O1 and non-O1 typing sera in rabbits immunized with polysaccharide-protein carrier conjugates. J ClinMicrobiol 19, 181-186.
2. Boutonnier, A., Villeneuve, S., Nato, F., Dassy, B. & Fournier, J.-M. (2001). Preparation, immunogenicity, and protective efficacy, in a murine model, of a conjugate vaccine composed of the polysaccharide moiety of the lipopolysaccharide of Vibrio cholerae O139 bound to tetanus toxoid. Infect Immun 69, 3488-3493. (Pubitemid 32332255)
3. Bradford, M. M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72, 248-254.
4. Castro, A., Bemer, V., Nóbrega, A., Coutinho, A. & Truffa-Bachi, P. (1998). Administration to mouse of endotoxin from Gram-negative bacteria leads to activation and apoptosis of T lymphocytes. Eur J Immunol 28, 488-495. (Pubitemid 28101724)
5. Chernyak, A., Kondo, S., Wade, T. K., Meeks, M. D., Alzari, P. M., Fournier, J. M., Taylor, R. K., Kovac, P. & Wade, W. F. (2002). Induction of protective immunity by synthetic Vibrio cholerae hexasaccharide derived from V. cholerae O1 Ogawa lipopolysaccharide bound to a protein carrier. J Infect Dis 185, 950-962. (Pubitemid 34274439)
6. Conway, M. A., Madrigal-Estebas, L., McClean, S., Brayden, D. J. & Mills, K. H. G. (2001). Protection against Bordetella pertussis infection following parenteral or oral immunization with antigens entrapped in biodegradable particles: effect of formulation and route of immunization on induction of Th1 and Th2 cells. Vaccine 19, 1940-1950. (Pubitemid 32178342)
7. de Andres, B., Mueller, A. L., Verbeek, S., Sandor, M. & Lynch, R. G. (1998). A regulatory role for Fcc receptors CD16 and CD32 in the development of murine B cells. Blood 92, 2823-2829. (Pubitemid 28469096)
8. de Andres, B., Hagen, M., Sandor, M., Verbeek, S., Rokhlin, O. & Lynch, R. G. (1999). A regulatory role for Fcc receptors (CD16 and 32) in hematopoiesis. Immunol Lett 68, 109-113. (Pubitemid 29265660)
9. Egan, W., Frasch, C. E. & Antony, B. F. (1995). Lot-release criteria, post licensure quality control and the Haemophilus influenzae type B conjugate vaccines. JAMA 273, 888-889.
10. Farkaš, P. & Bystrický, S. (2008). Hydrolysis of the terminal dimethylacetal moiety on the spacers bound to carboxy groups containing glucans. Carbohydr Polym 74, 133-136.
11. Goldblatt, D. (2000). Conjugate vaccines. Clin Exp Immunol 119, 1-3.
12. Gordon, S. (2007). The macrophage - past, present and future. Eur J Immunol 37, S9-S17.
13. Grandjean, C., Boutonnier, A., Dassay, B., Fournier, J.-M. & Mulard, L. A. (2009). Investigation towards bivalent chemically defined glycoconjugate immunogens prepared from acid-detoxified lipopolysaccharide of Vibrio cholerae O1, serotype Inaba. Glycoconj J 26, 41-55.
14. Gupta, R. K., Szu, S. C., Filkenstein, R. A. & Robbins, J. B. (1992). Synthesis, characterization, and some immunological properties of conjugates composed of the detoxified lipopolysaccharide of Vibrio cholerae O1 serotype Inaba bound to cholera toxin. Infect Immun 60, 3201-3208.
15. Gupta, R. K., Taylor, D. N., Bryla, D. A., Robbins, J. B. & Szu, S. C. (1998). Phase 1 evaluation of Vibrio cholerae O1, serotype Inaba, polysaccharide-cholera toxin conjugates in adult volunteers. Infect Immun 66, 3095-3099.
16. Guttormsen, H. K., Sharpe, A. H., Chandraker, A. K., Brigtsen, A. K., Sayegh, M. H. & Kasper, L. (1999). Cognate stimulatory B-cell-T-cell interactions are critical for T-cell help recruited by glycoconjugate vaccines. Infect Immun 67, 6375-6384.
17. Hirano, T., Jiao, X., Chen, Z., Waes, C. V. & Gu, X. X. (2006). Kinetics of mouse antibody and lymphocyte responses during intranasal vaccination with a lipooligosaccharide-based conjugate vaccine. Immunol Lett 107, 131-139. (Pubitemid 44779816)
18. Hisatsune, K., Yamamoto, F. & Kondo, S. (1985). Lipopolysaccharide of Vibrio cholerae: chemical and serological properties. In Advances in Research on Cholera and Related Diarrhoeas, pp. 17-24. Edited by S. Kuwahara & N. F. Pierce. Tokyo: KTK Scientific Publishers.
19. Jansen, W. T. M., Väkeväinen-Anttila, M., Käyhty, H., Nahm, M., Bakker, N., Verhoef, J., Snippe, H. & Verheul, A. F. M. (2001). Comparison of a classical phagocytosis assay and a flow cytometry assay for assessment of the phagocytic capacity of sera from adults vaccinated with a pneumococcal conjugate vaccine. Clin Diagn Lab Immunol 8, 245-250. (Pubitemid 32217051)
20. Kelly, D. F., Snape, M. D., Perrett, K. P., Clutterbuck, E. A., Lewis, S., Blanchard-Rohner, G., Jones, M., Yu, L.-M. & Pollard, A. J. (2009). Plasma and memory B-cell kinetics in infants following a primary schedule of CRM197-conjugated serogroup C meningococcal polysaccharide vaccine. Immunology 127, 134-143.
21. Kossaczka, Z., Shiloh, J., Johnsson, V., Taylor, D. N., Finkelstein, R. A., Robbins, J. B. & Szu, S. C. (2000). Vibrio cholerae O139 conjugate vaccines: synthesis and immunogenicity of Vibrio cholerae O139 capsular polysaccharide conjugates with recombinant diphtheria toxin mutant in mice. Infect Immun 68, 5037-5043.
22. Lefeber, D. J., Benaissa-Trouw, B., Vliegenthart, J. F. G., Kamerling, J. P., Jansen, W. T. M., Kraaijeveld, K. & Snippe, H. (2003). Th1- directing adjuvants increase the immunogenicity of oligosaccharide- protein conjugate vaccines related to Streptococcus pneumoniae type 3. Infect Immun 71, 6915-6920. (Pubitemid 37475322)
23. Machová, E., Bystrický, S., Gáliková, A. & Kogan, G. (2002). Preparation of a subcellular conjugate with the lipopolysaccharide from Vibrio cholerae 01 using β-D-glucan as matrix. Eur J Med Chem 37, 681-687. (Pubitemid 34874901)
24. Mosley, W. H., Feely, J. C. & Pittman, M. (1968). The interrelationships of serological responses in humans, and the active mouse protection test to cholera vaccine effectiveness. In International Symposium on Enterobacterial Vaccines. Series on Immunobiological Standards 1968, vol. 15, pp. 185-196. Edited by R. H. Regamey, M. Stanic & J. Ungar. Basel: Karger.
25. Palermo, M. S., Rosa, F. A., Alonso, G. F. & Isturiz, A. (1997). Fc-γ receptor-dependent clearance is enhanced following lipopolysaccharide in vivo treatment. Immunology 92, 536-543.
26. Paulovičová, E., Machová, E., Hoštacká , A. & Bystrický, S. (2006). Immunological properties of complex conjugates based on Vibrio cholerae O1 Ogawa lipopolysaccharide antigen. Clin Exp Immunol 144, 521-527.
27. Paulovičová, E., Kováčová, E. & Bystrický, S. (2010). Vibrio cholerae O1 Ogawa detoxified lipopolysaccharide structures as inducers of cytokines and oxidative species in macrophages. J Med Microbiol 59, 158-164.
28. Pierres, M., Rebouah, J. P., Kourilsky, F. M., Dosseto, M., Mercier, P., Mawas, C. & Malissen, B. (1981). Cross-reactions between mouse Ia and human HLA-D/DR antigens analyzed with monoclonal alloantibodies. J Immunol 126, 2424-2429. (Pubitemid 11072879)
29. Poulton, T. A., Gallagher, A., Potts, R. C. & Beck, J. S. (1988). Changes in activation markers and cell membrane receptors on human peripheral blood T lymphocytes during cell cycle progression after PHA stimulation. Immunology 64, 419-425.
30. Rodríguez, M. E., Van der Pol, W. L. & Van de Winkel, J. G. J. (2001). Flow cytometry-based phagocytosis assay for sensitive detection of opsonic activity of pneumococcal capsular polysaccharide antibodies in human sera. J Immunol Methods 252, 33-44.
31. Saksena, R., Ma, X., Wade, T. K., Kováč, P. & Wade, W. F. (2005). Effect of saccharide length on the immunogenicity of neoglycoconjugates from synthetic fragments of the O-SP of Vibrio cholerae O1, serotype Ogawa. Carbohydr Res 340, 2256-2269. (Pubitemid 41267005)
32. Saksena, R., Ma, X., Wade, T. K., Kováč, P. & Wade, W. F. (2006). Length of the linker and the interval between immunizations influences the efficacy of Vibrio cholerae O1, Ogawa hexasaccharide neoglycoconjugates. FEMS Immunol Med Microbiol 47, 116-128.
33. Salerno-Gonçalves, R. & Sztein, M. B. (2006). Cell-mediated immunity and the challenges for vaccine development. Trends Microbiol 14, 536-542. (Pubitemid 44755485)
34. Stuart, L. M. & Ezekowitz, R. A. B. (2005). Phagocytosis: elegant complexity. Immunity 22, 539-550.
35. Wade, W. F. (2006). B-cell responses to lipopolysaccharide epitopes: who sees what first - does it matter? Am J Reprod Immunol 56, 329-336.
36. Watanabe, Y. & Akaike, T. (1994). Activation signal induces the expression of B cell-specific CD45R epitope (6B2) on murine T cells. Scand J Immunol 39, 419-425. (Pubitemid 24227763)
37. Westphal, O. & Jann, K. (1965). Bacterial lipopolysaccharides: extraction with phenol-water and further applications of the procedure. Methods Carbohydr Chem 5, 83-91.
38. Zuercher, A. W., Imboden, M. A., Jampen, S., Bosse, D., Ulrich, M., Chtioui, H., Lauterburg, B. H. & Lang, A. B. (2005). Cellular immunity in healthy volunteers treated with an octavalent conjugate Pseudomonas aeruginosa vaccine. Clin Exp Immunol 142, 381-387. (Pubitemid 41565257)